SCHEMBL6091339

SCHEMBL6091339

CC(=O)Nc1cccc2cc[nH]c12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.57
▸ PGR P06401 1/20 0.57
▸ NR3C2 P08235 1/20 0.57
▸ AR P10275 1/20 0.57
▸ KEAP1 Q14145 1/20 0.50
▸ BCHE P06276 3/20 0.49
▸ PDPK1 O15530 1/20 0.49
▸ TRPV1 Q8NER1 1/20 0.48
▸ BTK Q06187 1/20 0.47
▸ BACE1 P56817 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ERCC1 P07992 1/20 0.46
▸ FEN1 P39748 1/20 0.46
▸ ERCC4 Q92889 1/20 0.46
▸ ROCK2 O75116 1/20 0.46
▸ ATR Q13535 1/20 0.44
▸ GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456523 1.00 NR3C1 (0.57) NR3C1PGRNR3C2ARKEAP1
SCHEMBL27698981 0.84 KEAP1 (0.56) NR3C1PGRNR3C2ARKEAP1
SCHEMBL25581593 0.83 NR3C1 (0.54) NR3C1PGRNR3C2ARKEAP1
SCHEMBL30026274 0.83 PDPK1 (0.57) NR3C1PGRNR3C2ARKEAP1
SCHEMBL5497010 0.83 PDPK1 (0.57) NR3C1PGRNR3C2ARKEAP1
SCHEMBL4006303 0.80 ROCK2 (0.57) TRPV1BTKALDH1A1HPGDKDM4E
SCHEMBL31668711 0.80 TRPV1 (0.65) NR3C1PGRNR3C2ARKEAP1
SCHEMBL21920694 0.79 NR3C1 (0.49) NR3C1PGRNR3C2ARKEAP1
SCHEMBL30087920 0.79 NR3C1 (0.49) NR3C1PGRNR3C2ARKEAP1
SCHEMBL21481533 0.79 NR3C1 (0.52) NR3C1PGRNR3C2ARKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113015526-A Spirocyclic 2, 3-dihydro-7-azaindole compounds and uses thereof 豪夫迈·罗氏有限公司 2021-06-22 — — CN disclosed
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 — — US disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 — — EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R NR3C1 4/4885PGR 148/4885NR3C2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback